Key Highlights

  • NewGenIvf Group Limited (NASDAQ:NIVF) reached USD 1.40, up 21.30%, in pre-market trading on Wednesday, October 28, 2026. No company announcement dated on or just before that day came with the move, and the latest release is dated Wednesday, September 30, 2026.
  • For the year ended Thursday, December 31, 2025, the company reported net profit of USD 9.9 million and net assets of about USD 25.98 million, according to its annual report for that year.
  • The company holds 10% of K25.ai at a USD 100 million valuation and agreed on Monday, July 27, 2026 to buy a further 3% for USD 7.5 million at a USD 250 million valuation.
  • A public offering closed on Wednesday, September 30, 2026, raising gross proceeds of about USD 1.25 million at USD 0.07 a share. Dilution and Nasdaq market value requirements remain caveats, and pre-market liquidity is thin.

What Lies Behind the Pre-Market Climb

NewGenIvf Group Limited (NASDAQ:NIVF), a business with fertility-related operations and technology investments including a stake in K25.ai, traded at USD 1.40 in pre-market trading on Wednesday, October 28, 2026, a gain of 21.30% on the snapshot. Simple arithmetic implies a prior close near USD 1.15. No company-specific announcement dated on or just before Wednesday, October 28, 2026 accompanied the move. The latest release, from Wednesday, September 30, 2026, reported the close of a public offering, so the advance looks consistent with thin trading in a very small stock. Market data show capitalisation near USD 1.02 million on an undated basis. Pre-market prices can shift before the 9:30 a.m. ET open.

How the Offering and K25.ai Holding Shape the Move

A release dated Monday, September 28, 2026 priced 17,857,143 shares or pre-funded warrants at USD 0.07 each. The offering closed on Wednesday, September 30, 2026 with gross proceeds of about USD 1.25 million, with Aegis Capital as placement agent. Stated uses include the K25.ai investment, debt restructuring, machine manufacturing and working capital. The USD 1.40 pre-market price is twenty times the offering price, a gap that may reflect a share consolidation since then. That is an inference, not a confirmed event. NewGenIvf Group Limited (NASDAQ:NIVF) said on Thursday, July 30, 2026 that its expected 13% stake in K25.ai is valued at about USD 26 million, an expected unrealised gain of about USD 8.5 million. It also exchanged convertible notes on Friday, August 14, 2026.

Bull Case, Bear Case and Next Dates

The optimistic view is that the K25.ai stake, which the company values at about USD 26 million once the further purchase completes, is large relative to market capitalisation. The skeptical view is that the stake is an unrealised valuation, the offering was priced at a steep discount and the company relies on repeated capital raises. Specific risks include dilution, a Nasdaq market value requirement the company has linked to its share issuances, debt under a forbearance agreement dated Tuesday, June 16, 2026 and limited liquidity. Watch the first prices after the 9:30 a.m. ET open, the Federal Reserve decision later on Wednesday, October 28, 2026, completion of the K25.ai purchase and any Nasdaq notice.

Where Things Stand

NewGenIvf Group Limited (NASDAQ:NIVF) rose 21.30% pre-market on Wednesday, October 28, 2026 with no company statement behind it, which fits light trading in a very small stock. The most telling figure is the company's roughly USD 26 million valuation of its expected K25.ai stake. Upcoming markers are the 9:30 a.m. ET open, the Federal Reserve decision later on Wednesday, October 28, 2026 and the completion of the extra K25.ai purchase. Pre-market prices move, and this is not investment advice.